The ROE as of November 2024 (TTM) for Clearside Biomedical, Inc. (CLSD) is 126.50%

According to Clearside Biomedical, Inc.’s latest financial reports and current stock price. The company's current ROE is 126.50%. This represents a change of 279.75% compared to the average of 33.31% of the last 4 quarters.

Clearside Biomedical, Inc. (CLSD) Historical ROE (quarterly & annually)

How has CLSD ROE performed in the past?

The mean historical ROE of Clearside Biomedical, Inc. over the last ten years is -115.67%. The current 126.50% ROE has changed -209.36% with respect to the historical average. Over the past ten years (40 quarters), CLSD's ROE was at its highest in in the June 2023 quarter at 183.11%. The ROE was at its lowest in in the March 2023 quarter at -486.00%.

Clearside Biomedical, Inc. (CLSD) ROE by Quarter and Year

Discovering the peaks and valleys of Clearside Biomedical, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Clearside Biomedical, Inc. (CLSD) Average ROE

How has CLSD ROE performed in the past?

The current ROE of Clearside Biomedical, Inc. (CLSD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Clearside Biomedical, Inc. (CLSD) ROE vs. Peers

How is CLSD’s ROE compared to its peers?

Clearside Biomedical, Inc.’s ROE is greater than POINT Biopharma Global Inc. (-11.52%), greater than ORIC Pharmaceuticals, Inc. (-42.46%), greater than Lyra Therapeutics, Inc. (-178.68%), less than Inhibrx Biosciences, Inc. (1.45%), greater than ESSA Pharma Inc. (-20.17%), greater than Sensei Biotherapeutics, Inc. (-53.86%), greater than NextCure, Inc. (-62.50%), greater than Nuvation Bio Inc. (-108.68%), greater than Graphite Bio, Inc. (-57.96%), greater than Merrimack Pharmaceuticals, Inc. (-35.28%), greater than Gracell Biotechnologies Inc. (-15.56%), greater than Theseus Pharmaceuticals, Inc. (-12.35%), greater than Monte Rosa Therapeutics, Inc. (-62.68%), greater than Design Therapeutics, Inc. (-18.01%), greater than Erasca, Inc. (-42.26%), greater than Eyenovia, Inc. (-1243.79%), greater than Alpha Tau Medical Ltd. (-38.62%), greater than Ocular Therapeutix, Inc. (-56.75%), greater than Tenaya Therapeutics, Inc. (-86.16%), greater than Inozyme Pharma, Inc. (-88.42%), greater than Generation Bio Co. (-104.85%), greater than Kronos Bio, Inc. (-64.55%), greater than C4 Therapeutics, Inc. (-42.45%), greater than Edgewise Therapeutics, Inc. (-26.83%),

Build a custom stock screener for Clearside Biomedical, Inc. (CLSD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clearside Biomedical, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Clearside Biomedical, Inc. (CLSD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Clearside Biomedical, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.